In case you missed it, our Open Meeting 2025 program is out now. From prehospital transfusion to home-based care - and everything in between - join us for the latest research updates, collaborative activities, and methods to improve blood use. More at: https://t.co/exmAZNBGGV
The program for our Blood Synergy Open Meeting 2025 is now available. If you're interested in transfusion research, please join us for this hybrid meeting on May 27th. To find more information about the meeting, and how to register, visit: https://t.co/exmAZNBGGV
Thanks to everyone who participated in @treatt_trial! And thanks to @nhmrc and @ANZSBT for supporting the Australian arm of the trial. Great to see it published today!
What trial of transfusion support in trauma should we do next? Thanks everyone for a fantastic @BloodSynergy workshop at the @TraumaANZ conference in Brisbane today!
RMH @TheRMH recruits in the first week of going live! Many thanks to the trauma team @TraumaKate_Au Excited to have both MTC in Victoria recruiting @BloodSynergy@anzicrc@TraumaANZ
Our good friends at the Myeloma & Related Diseases Registry are holding their annual Breakfast Meeting at the Blood 2024 conference in Brisbane on Oct 28th. Join the meeting in person or online. For more information & to register visit:
https://t.co/NicKAs24kx
We're so very pleased to announce that the Blood Synergy received further @nhmrc synergy funding to continue our research program. Congratulations to all our wonderful team and collaborators!
We are super-exited that our @BloodSynergy has secured a further 5 years of @nhmrc funding!
Our research focusses on making better use of blood, with new knowledge to improve stewardship of Australia’s national blood supplies and outcomes for patients.
https://t.co/OEu9qbISun
Our good friends at the Myeloma & Related Diseases Registry are holding their annual Breakfast Meeting at the Blood 2024 conference in Brisbane on Oct 28th. Join the meeting in person or online. For more information & to register visit:
https://t.co/NicKAs24kx
On #WorldPatientSafetyDay, recognising the importance of patients and healthcare professionals working together and speaking up for blood transfusion safety 🩸🩸🩸
@LaRDRregistry generates real-world evidence to improve lymphoma diagnosis & care, and inform optimal treatment strategies for patients outside of trials. We proudly partner with consumer representatives @lymphomaOz to address patients’ needs. @BloodSynergy#WorldPatientSafetyDay
We're excited to be convening the Transfusion in Trauma workshop at the Trauma 2024 meeting. Registration now open! Please join us if you're interested in shaping future trauma trials
Pre-conference workshops now available:
Multidisciplinary Trauma Forum
Critical Decision Making in Trauma Workshop
Transfusion in Trauma: what trial do we do next?
https://t.co/3ep1Yz4mJJ
Heading home after #ISBTBarcelona! Thank you to @ISBTCO and @SETS_es for a wonderful congress, and to my Transfusion Research Unit and @bloodsynergy colleagues Allison Mo, Sara Carrillo and Neil Waters for excellent contributions
Thanks to everyone who participated in the @BloodSynergy community consultation on transfusion research priorities for Australia!
First results presented by Neil Waters today at #ISBTBarcelona, with more information to follow at https://t.co/OEu9qbIkEP
Congratulations to @BielbyLinley on receiving an ISBT Award today at #ISBTBarcelona, reflecting her major contributions to transfusion education, practice and research internationally!
#ISTH2024 State-of-the-Art
James Winearls (@WinearlsJ) presents "Factor concentrates therapy in major bleeding" SOA 03.3 8:50AM 23 June.
#coagcapsule
Read the illustrated capsule here:
https://t.co/XO4rQgH0I0
Is ultra-massive transfusion futile?
@MarsaliMaclean shared @BloodSynergy Australian & NZ Massive Transfusion Registry data at #EHA2024 indicating many patients with major bleeding who receive 20+ RBCs within 48h survive to hospital discharge + long-term
https://t.co/FkTycH2V7G